DECIPHER LABS LIMITED Share Price

DECIPHER LABS LIMITED Share Price

BSE: 524752
|
Pharmaceuticals
|
S Cap
₹ 5.70
+₹0.10 (1.79%)
1D
Last updated 09 Sep, 2026, 15:15 IST

DECIPHER LABS LIMITED Share Price Today

As of 9 Sep 2026, DECIPHER LABS LIMITED share price is ₹5.70. The stock opened at ₹5.60, compared to its previous close of ₹5.60. During today's trading session, DECIPHER LABS LIMITED share price moved in the range of ₹5.60 to ₹5.70, with an average price of ₹5.65 for the day. Looking at its last 52-week, the stock has touched a low of ₹5.00 and a high of ₹11.20.

₹5.60
1.79% up today
₹5.70
1D LOW
1D HIGH

DECIPHER LABS LIMITED Returns Calculator

Circuit
L
H
₹4.48
₹6.72
52-week
L
H
₹5.00
₹11.20

About DECIPHER LABS LIMITED

DECIPHER LABS LIMITED Share Price
ISIN
INE643N01012
Sector Market Cap
₹ 5.66 Cr

Decipher Labs Limited is an India-based company, which is engaged in the manufacture and marketing of pharmaceuticals and allied products and services. The Company’s segment includes pharmaceuticals and consultancy. It also provides services to the information technology industry. The Company also caters to various formulators, manufacturers and research and development agencies for their bulk needs and sources and supplies various drugs and allied chemicals and allied products and services to the companies upon request. The Company offers a range of services, including technology integration and systems consulting, software development consulting, and management of information technology (IT) projects. The Company’s wholly owned subsidiary is Decipher Software Solutions LLC.

DECIPHER LABS LIMITED Financial Highlights

  • Revenue: DECIPHER LABS LIMITED reported revenue of ₹14.27 crore in FY26 vs ₹23.93 crore in FY25. It showed a decrease of 40.37% on a yearly basis.
  • Operating Profit: DECIPHER LABS LIMITED reported an operating loss of ₹3.68 crore in FY26 vs ₹6.39 crore in FY25. It showed an increase of 42.41% on a year-on-year basis.
  • Net Profit: DECIPHER LABS LIMITED reported a net loss of ₹3.08 crore in FY26 vs ₹5.08 crore in FY25. It showed an increase of 39.37% on a yearly basis.

DECIPHER LABS LIMITED Quarterly Result Highlights

  • DECIPHER LABS LIMITED reported revenue of ₹2.51 crore in Jun 2026, compared with ₹3.77 crore in Mar 2026, representing a decrease of 33.42% on a quarter-on-quarter (QoQ) basis.
  • DECIPHER LABS LIMITED reported an operating loss of ₹2.19 crore in Jun 2026, compared with ₹0.25 crore in Mar 2026, representing a decrease of 976.00% on a quarter-on-quarter (QoQ) basis.
  • DECIPHER LABS LIMITED reported a loss of ₹2.19 crore in Jun 2026, compared with ₹0.36 crore in Mar 2026, reflecting a decrease of 508.33% on a QoQ basis.
  • The earnings per share (EPS) of DECIPHER LABS LIMITED stood at ₹5.03 during Jun 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Know more
Promoters
16.43%
FII
0.00%
Other DII
0.00%
Retail and other
83.57%
Mutual funds
0.00%
Foreign Institutional Investor (FII)
FII shareholding by period
Sep 20250.00%
Dec 20250.00%
Mar 20260.00%
Jun 20260.00%
Mkt Cap Cr
5.66
P/E
-1.85
P/B
0.27
ROE
-14.93%
D/E
0.06
ROCE
-17.41%
Div. Yield
0.00%
EPS(TTM)
-0.24
Turnover
0.04
EV/EBITDA
-2.81
Net Margin
0.00%
Op. Margin
0.00%
ROA
-12.62%
Quick Ratio
0.00
Curr. Ratio
0.67
Based on fundamentals, this stock's
Step 1 of 5
Performance
Very Poor
Decipher Labs has not beaten FD return of 7%
Step 1 of 5
Valuation
Overvalued
Decipher Labs appears overvalued compared to its peers
Step 3 of 5
Earnings
Neutral
Decipher Labs earnings growth is positive
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROED/EROCEBook ValueDiv. YieldTurnoverEPS(TTM)
Sun Pharmaceutical Industries4,51,339.0037.255.4013.74%0.6117.33%93.240.85%0.4810.90
Divis Laboratories2,54,068.0086.8615.1615.32%0.0019.56%629.490.31%0.5598.19
Torrent Pharmaceuticals1,88,767.0087.5622.4525.49%1.6913.85%222.760.68%0.4958.70
Zydus Lifesciences1,14,713.0024.984.2318.59%0.3117.35%237.300.09%0.3335.38
Cipla1,11,804.0033.323.2511.27%0.0014.95%423.360.94%0.4543.52
Laurus Labs1,05,118.0096.4119.8316.77%0.4016.14%97.200.10%0.6713.72
Lupin96,574.5017.404.3023.76%0.0424.88%659.000.85%0.57129.18
Mankind Pharma95,242.0046.065.8411.74%0.3413.13%396.980.04%0.4449.37
Dr. Reddy's Laboratories96,113.4030.192.5211.07%0.1812.54%377.950.70%0.4138.68
Aurobindo Pharma97,008.7026.142.569.25%0.1911.76%394.820.24%0.3841.58

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

DECIPHER LABS LIMITED Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Revenue₹22.61₹35.88₹45.57₹65.32
Other Income₹1.32₹0.42₹7.37₹7.67
Total Revenue₹23.93₹36.30₹52.94₹73.00
Total Expenses₹30.32₹37.51₹54.86₹60.64
Profit Before Tax-₹6.39-₹1.21-₹4.16₹12.36
Tax-₹1.31₹0.46-₹1.48₹0.97
Profit After Tax-₹5.08-₹1.68-₹2.68₹11.38
EPS - Basic-₹5.03-₹1.66-₹2.66₹11.27
EPS - Diluted-₹5.03-₹1.66-₹2.66₹11.27

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Profit before tax-₹6.39-₹1.21-₹4.16₹12.36
Income before WC changes₹0.34-₹0.21-₹6.87₹7.02
Change in Assets-₹1.09-₹2.70₹8.50₹0.35
Change in Liabilities-₹9.06₹7.77-₹3.19₹0.89
Change in WC-₹10.16₹5.07₹5.30₹1.25
Cash flow from Operations-₹9.82₹4.85-₹1.56₹8.26
Cash flow from Investing₹3.07-₹1.79-₹4.28-₹0.45
Cash flow from Financing₹0.24-₹1.17-₹2.15₹1.30
Total Cash Flow-₹6.51₹1.90-₹7.99₹9.11
Cash (Start of the year)₹9.31₹7.42₹15.41₹6.98
Cash (End of the year)₹2.81₹9.31₹7.42₹15.41

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Non-Current Assets₹4.71₹8.96₹8.08₹3.72
Current Assets₹21.05₹24.68₹20.08₹38.23
Total Assets₹25.76₹33.63₹28.16₹41.95
Current Liabilities₹2.91₹11.77₹4.96₹11.11
Net Current Asset₹18.14₹12.91₹15.13₹27.12
Non-Current Liabilities₹0.00₹0.00₹0.00₹6.68
Equity Capital₹22.86₹21.86₹23.21₹24.17
Total Equity & Liabilities₹25.76₹33.63₹28.16₹41.95

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Revenue₹0.85₹3.53₹0.81₹0.99
Other Income₹0.02₹0.02₹0.03₹0.05
Total Revenue₹0.88₹3.55₹0.84₹1.03
Total Expenses₹1.31₹3.53₹1.24₹0.68
Profit Before Tax-₹0.44₹0.03-₹2.64₹0.36
Tax₹0.00₹0.00-₹0.02₹0.00
Profit After Tax-₹0.44₹0.02-₹2.62₹0.36
EPS - Basic-₹0.44₹0.02-₹2.59₹0.36
EPS - Diluted-₹0.44₹0.02-₹2.59₹0.36

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Profit before tax-₹0.44₹0.03-₹2.64₹0.36
Income before WC changes-₹0.43₹0.04-₹0.27₹0.42
Change in Assets₹3.64-₹3.82₹0.19₹0.12
Change in Liabilities-₹3.14₹3.75₹0.01₹0.01
Change in WC₹0.50-₹0.07₹0.19₹0.13
Cash flow from Operations₹0.07-₹0.03-₹0.08₹0.55
Cash flow from Investing-₹0.05₹0.00₹0.09-₹0.38
Cash flow from Financing₹0.00₹0.00₹0.00-₹0.14
Total Cash Flow₹0.03-₹0.03₹0.01₹0.03
Cash (Start of the year)₹0.03₹0.06₹0.05₹0.02
Cash (End of the year)₹0.05₹0.03₹0.06₹0.05

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Non-Current Assets₹8.85₹8.79₹8.81₹9.00
Current Assets₹0.32₹3.97₹0.18₹2.60
Total Assets₹9.18₹12.76₹8.99₹11.60
Current Liabilities₹0.69₹3.83₹0.09₹0.08
Net Current Asset-₹0.37₹0.14₹0.10₹2.52
Non-Current Liabilities₹0.00₹0.00₹0.00₹0.00
Equity Capital₹8.49₹8.93₹8.90₹11.52
Total Equity & Liabilities₹9.18₹12.76₹8.99₹11.60
* All values are in INR Crore
Qty
Bid
191
5.7
0
0
0
0
0
0
0
0
Ask
Qty
0
0
0
0
0
0
0
0
0
0
Bid Total: 191
Ask Total: 0
Buy orders: 100%
Sell orders: 0%
Bearish
2
Neutral
6
Bullish
0
Slightly Bearish
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
Indicator
Value
Verdict
RSI (14)
44.34
Neutral
ATR (14)
0.38
Neutral
STOCH(9,6)
30
Neutral
STOCH RSI (14)
42.87
Neutral
ADX(9)
39.01
Bearish
UO(9)
52.33
Neutral
ROC(12)
-2.61
Bearish
WillR(14)
-70
Neutral
Period
Simple value
Exponential vaue
5D
5.73
5.69
10D
5.67
5.71
20D
5.8
5.81
50D
6.16
6.12
100D
6.71
6.53
Volume trend — traded volume by day
9 Sep0L
8 Sep0L
7 Sep0L
4 Sep0L
3 Sep0L
2 Sep0L
Average0L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks
DECIPHER LABS LIMITED Share Price
DECIPHER LABS LIMITED
Pharmaceuticals
Add Stock
Add Another

DECIPHER LABS LIMITED Share Price FAQs

DECIPHER LABS LIMITED share price data is sourced from NSE/BSE and may be delayed. It is displayed for informational purposes only and does not constitute investment advice or a recommendation to buy or sell.

Trusted by 2 Crore+ Indians for their wealth-building needs. SEBI Registered Broker. SEBI Reg No. INZ000315837